AR123039A1 - COAGONISTS OF GLP-1 AND GIP RECEPTORS - Google Patents

COAGONISTS OF GLP-1 AND GIP RECEPTORS

Info

Publication number
AR123039A1
AR123039A1 ARP210102059A ARP210102059A AR123039A1 AR 123039 A1 AR123039 A1 AR 123039A1 AR P210102059 A ARP210102059 A AR P210102059A AR P210102059 A ARP210102059 A AR P210102059A AR 123039 A1 AR123039 A1 AR 123039A1
Authority
AR
Argentina
Prior art keywords
coagonists
glp
gip receptors
gip
receptors
Prior art date
Application number
ARP210102059A
Other languages
Spanish (es)
Inventor
Patrick J Knerr
Brian Finan
Fa Liu
Richard Dimarchi
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of AR123039A1 publication Critical patent/AR123039A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen coagonistas peptídicos de los receptores de GLP1 y GIP humanos, sus derivados de acción prolongada y sus usos médicos en el tratamiento y/o prevención de la obesidad, la diabetes y/o enfermedades hepáticas.Peptide coagonists of human GLP1 and GIP receptors, their long-acting derivatives, and their medical uses in the treatment and/or prevention of obesity, diabetes, and/or liver diseases are disclosed.

ARP210102059A 2020-07-22 2021-07-22 COAGONISTS OF GLP-1 AND GIP RECEPTORS AR123039A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063055063P 2020-07-22 2020-07-22

Publications (1)

Publication Number Publication Date
AR123039A1 true AR123039A1 (en) 2022-10-26

Family

ID=83835147

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102059A AR123039A1 (en) 2020-07-22 2021-07-22 COAGONISTS OF GLP-1 AND GIP RECEPTORS

Country Status (1)

Country Link
AR (1) AR123039A1 (en)

Similar Documents

Publication Publication Date Title
CL2023000087A1 (en) Glp-1 and gip receptor coagonists suitable for oral delivery
CL2020002796A1 (en) Derivatives of gip and uses of these
PE20170087A1 (en) COMPOSITION TO TREAT DIABETES MELLITUS, INCLUDING INSULIN AND A GLP-1 / GLUCAGON DOUBLE AGONIST
GT201500049A (en) FUSION PROTEINS FOR THE TREATMENT OF A METÀBOLIC SYNDROME
UY29020A1 (en) SALICILTIAZOLES REPLACED WITH DIFENYLAMINE OR DERIVATIVES OF DIFENYLAMINE, PROCEDURES FOR PREPARATION AND USE.-
CL2019003660A1 (en) Dosages for the administration of glucagon-2-like peptide analogs (glp-2).
ECSP21051825A (en) COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
BR112021013415A2 (en) Multifunctional fusion proteins and uses thereof
CL2023000090A1 (en) Glp-1 and gip receptor coagonists
CR11562A (en) BIS-PIRIDILPIRIDONAS AS ANTAGONISTS OF THE RECEIVER 1 OF THE CONCENTRATING HORMONE OF MELANINA
CL2021001073A1 (en) Protein tyrosine-tyrosine analogs and methods of using it
CL2017002293A1 (en) Treatment of patients with type 2 diabetes mellitus
AR111374A1 (en) USE OF LIK066 IN PATIENTS WITH HEART FAILURE
EA202190744A1 (en) GLP1-FC FUSION PROTEIN AND ITS CONJUGATE
PE20181332A1 (en) METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING THE TREATMENT OF CRITICAL CARE
CL2021002521A1 (en) Heteocyclic compounds and their uses.
CO2023008676A2 (en) Lactam modified polypeptide compounds
CL2021000129A1 (en) Solubilized apyrases, methods and uses
DOP2019000100A (en) DERIVATIVES OF NAFTIRIDINONE AND ITS USE IN THE TREATMENT OF ARRITMIA
CL2021002397A1 (en) Glucose-sensitive insulin derivatives
PE20221410A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER, INCLUDING IMMUNE CHECKPOINT INHIBITOR AND FUSION PROTEIN INCLUDING IL-2 PROTEIN AND CD80 PROTEIN
ECSP22019177A (en) NKG2D FUSION PROTEINS AND THEIR USES
CL2020000508A1 (en) Anti-egfr drug-antibody (adc) conjugates and their uses.
CR20170121A (en) ANAMORELINE COMPOUNDS AND ITS USES
AR123039A1 (en) COAGONISTS OF GLP-1 AND GIP RECEPTORS